Newbridge Financial Services Group’s Mereo BioPharma MREO Stock Holding History

Newbridge Financial Services Group’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.96K	Hold	18,750	–	–	﹤0.01%	938
2026 Q1	$6.19K	Buy	18,750 +1,750	+10%	+$751	﹤0.01%	876
2025 Q4	$7.08K	Buy	17,000 +4,000	+31%	+$7.61K	﹤0.01%	839
2025 Q3	$26.8K	Hold	13,000	–	–	﹤0.01%	670
2025 Q2	$35.2K	Buy	13,000 +2,000	+18%	+$4.83K	0.01%	578
2025 Q1	$24.8K	Buy	11,000 +300	+3%	+$849	0.01%	499
2024 Q4	$37.5K	Buy	+10,700	New	+$42K	0.01%	472
2024 Q3	–	Sell	-11,700	Closed	-$42.1K	–	935
2024 Q2	$42.1K	Hold	11,700	–	–	0.02%	406
2024 Q1	$38.6K	Buy	11,700 +2,200	+23%	+$7.45K	0.02%	449
2023 Q4	$21.9K	Buy	+9,500	New	+$18.2K	0.01%	574
2023 Q3	–	Sell	-9,500	Closed	-$12.5K	–	1368
2023 Q2	$12.5K	Buy	9,500 +2,500	+36%	+$2.9K	0.01%	836
2023 Q1	$4.95K	Buy	7,000 +3,000	+75%	+$2.7K	﹤0.01%	1072
2022 Q4	$3K	Hold	4,000	–	–	﹤0.01%	1154
2022 Q3	$3K	Hold	4,000	–	–	﹤0.01%	1138
2022 Q2	$4K	Hold	4,000	–	–	﹤0.01%	1059
2022 Q1	$4K	Hold	4,000	–	–	﹤0.01%	1149
2021 Q4	$6K	Hold	4,000	–	–	﹤0.01%	1034
2021 Q3	$10K	Hold	4,000	–	–	0.01%	870
2021 Q2	$13K	Hold	4,000	–	–	0.01%	910
2021 Q1	$13K	Buy	+4,000	New	+$14.1K	0.01%	824

Other funds holding MREO

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Newbridge Financial Services Group's MREO Position: Q2 2026 in Review

Newbridge Financial Services Group held its Mereo BioPharma (MREO) position steady in Q2 2026 at 18,750 shares worth $5.96K. The position accounts for ﹤0.01% of the portfolio, ranked #938.

Newbridge Financial Services Group first reported a position in MREO in Q1 2021 and has held it in 20 quarters since. The position peaked at $42.1K in Q2 2024. 61 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

Newbridge Financial Services Group held 18,750 shares of Mereo BioPharma worth $5.96K as of Q2 2026.
Newbridge Financial Services Group left its Mereo BioPharma share count unchanged in Q2 2026.
Mereo BioPharma made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #938 holding.
Newbridge Financial Services Group first reported a position in Mereo BioPharma in Q1 2021 and has held it in 20 quarters since.
Newbridge Financial Services Group's Mereo BioPharma position peaked at $42.1K in Q2 2024.
61 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.